Open AccessSARILUMAB FOR RECALCITRANT CYSTOID MACULAR EDEMA IN NON-PARANEOPLASTIC AUTOIMMUNE RETINOPATHY
Author(s) -
Dilraj S. Grewal,
Glenn J. Jaffe,
Robert T. Keenan
Publication year - 2021
Publication title -
retinal cases and brief reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 14
eISSN - 1937-1578
pISSN - 1935-1089
DOI - 10.1097/icb.0000000000000872
Subject(s) - medicine , macular edema , retinopathy , fluorescein angiography , optic neuropathy , azathioprine , ophthalmology , adverse effect , retinal vasculitis , immunosuppression , vasculitis , dermatology , visual acuity , optic nerve , disease , diabetes mellitus , endocrinology
To demonstrate a rapid improvement of recalcitrant cystoid macular edema (CME) and perivascular leakage, in a patient with non-paraneoplastic autoimmune retinopathy and autoimmune optic neuropathy after treatment with sarilumab, a human anti-interleukin-6 (IL-6) receptor antibody.